经皮腔内肺动脉成形术治疗慢性血栓栓塞性肺高血压1例  

Percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:a case report

作　　者：杨尹鉴 郭帆 周玉平 徐希奇 荆志成 YANG Yin-jian;GUO Fan;ZHOU Yu-ping;XU Xi-qi;JING Zhi-cheng(Department of Medical Research Center,Department of Cardiology,State Key Laboratory of Complex,Severe,and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;不详)

机构地区：[1]中国医学科学院、北京协和医学院、北京协和医院、疑难重症及罕见病国家重点实验室、医学科学研究中心,北京100730 [2]中国医学科学院、北京协和医学院、北京协和医院、疑难重症及罕见病国家重点实验室、心内科,北京100730 [3]南方医科大学附属广东省人民医院(广东省医学科学院)心内科广东省心血管病研究所

出　　处：《中国介入心脏病学杂志》2023年第12期951-954,共4页Chinese Journal of Interventional Cardiology

基　　金：中央高水平医院临床科研专项项目(2022-PUMCH-B-099)。

摘　　要：本文报道1例慢性血栓栓塞性肺高血压患者,在给予抗凝治疗和肺动脉高压靶向药物治疗的基础上,采用经皮腔内肺动脉成形术分期治疗后病情明显改善,肺动脉平均压由51 mmHg降低为20 mmHg,世界卫生组织(WHO)心功能分级由Ⅲ级提高为Ⅰ级,接近治愈,为临床上类似病例的治疗提供借鉴。This paper reports that one patient with chronic thromboembolic pulmonary hypertension was significantly improved and close to cure after staged treatment with percutaneous transluminal pulmonary angioplasty on the basis of anticoagulant therapy and pulmonary arterial hypertension-targeted medical therapy.The mean pulmonary artery pressure decreased from 51 mmHg to 20 mmHg.The World Health Organization(WHO)f unctional class improved fromⅢtoⅠ.This case provides a reference for the treatment of chronic thromboembolic pulmonary hypertension in clinical practice.

关 键 词：慢性血栓栓塞性肺高血压 经皮腔内肺动脉成形术 肺栓塞 

分 类 号：R54[医药卫生—心血管疾病]